Danaher Corporation reported Q3 results showing an 8.3% year-over-year revenue increase, primarily driven by acquisitions and tariff refunds rather than organic growth. The company achieved an adjusted operating margin of 29%, surpassing guidance, but improvements in organic growth and profitability were modest and partly non-recurring. Management's guidance for Q4 suggests earnings per share may fall short of expectations, and the new CEO emphasized the need for stronger growth and better operational execution. Investors are advised to remain cautious until Danaher demonstrates clearer strategic direction and sustained improvements in organic growth and profitability.
Danaher Corporation shares are up 2.92% on Pluang, trading at USD 230.56 as of Oct 22, 2026 00:22 WIB. The stock shows a market cap of $157.64 billion with a dividend yield of 0.71%, while most Pluang investors are currently selling, with 79% of order activity on the sell side.
Danaher reported Q3 2026 earnings per share of $2.11, surpassing analyst estimates of $1.92, although revenue slightly missed expectations at $6.55 billion versus $6.56 billion forecast. The company highlighted improving customer demand and faster co...
Danaher Corporation reported strong Q3 2026 results with net earnings rising 34.5% year-over-year to $1.2 billion, or $1.71 per diluted share. Revenues increased 8.5% to $6.6 billion, driven by core growth excluding respiratory revenue. The company r...
